B-Raf proto-oncogene, serine/threonine kinase (BRAFV600E), and telomerase reverse transcriptase (TERT) promoter mutations were the most frequently identified in papillary thyroid carcinoma. Here, MARK2 is linked to differentiated thyroid carcinoma.